Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5645495 | Annals of Allergy, Asthma & Immunology | 2016 | 8 Pages |
Abstract
In this epidemiologic study, the rate of recurrence was 8% during the 10-year study period (recurrence rate of 2.6 per 100 person-years). Those with atopic dermatitis and mucocutaneous or respiratory symptoms were more likely to have a recurrent anaphylactic event. Our findings underscore the importance of early patient access to self-injectable epinephrine and referral to an allergist/immunologist for additional testing and education.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Sangil MD, MS, Curtis BS, Christine M. MS, M. Fernanda MD, MS, Alanna PhD, Kumi MD, Erik P. MD, MSc, Ronna L. MD, PhD,